APA (7th ed.) Citation

Hong, R., Lin, C., Chao, T., Kao, W., Wang, C., Hsieh, R., & Hwang, W. (2008). A phase-I study evaluating the combination of pegylated liposomal doxorubicin and paclitaxel as salvage chemotherapy in metastatic breast cancer previously treated with anthracycline. Cancer Chemotherapy & Pharmacology, 61(5), 847. https://doi.org/10.1007/s00280-007-0542-4

Chicago Style (17th ed.) Citation

Hong, Ruey-Long, Ching-Hung Lin, Tsu-Yi Chao, Woei-You Kao, Cheng-Hsu Wang, Ruey Hsieh, and Wei-Shou Hwang. "A Phase-I Study Evaluating the Combination of Pegylated Liposomal Doxorubicin and Paclitaxel as Salvage Chemotherapy in Metastatic Breast Cancer Previously Treated with Anthracycline." Cancer Chemotherapy & Pharmacology 61, no. 5 (2008): 847. https://doi.org/10.1007/s00280-007-0542-4.

MLA (9th ed.) Citation

Hong, Ruey-Long, et al. "A Phase-I Study Evaluating the Combination of Pegylated Liposomal Doxorubicin and Paclitaxel as Salvage Chemotherapy in Metastatic Breast Cancer Previously Treated with Anthracycline." Cancer Chemotherapy & Pharmacology, vol. 61, no. 5, 2008, p. 847, https://doi.org/10.1007/s00280-007-0542-4.